Evolva Holding SA (SIX: EVE) announces the start of commercial production of its resveratrol ingredient. Evolva has succeeded in optimizing and scaling the fermentation process, resulting in competitive production costs that allow a commercial launch. Evolva’s resveratrol is high-purity (>98% pure trans-Resveratrol), with a controlled and reliable supply chain, produced from natural and sustainable feedstocks. It is the only resveratrol product made by brewing.
Evolva has appointed a contract manufacturer in North America to produce commercial batches of resveratrol and expects to receive first deliveries in Q3 2014. Work on further reducing production costs will continue post-launch. Discussions with a global network of distributors are ongoing to accelerate sales post-launch.
Evolva has commenced pre-launch commercial activities and will attend the Institute of Food Technologist (IFT) Annual Meeting and Food Expo on June 22 to 24 (New Orleans, USA). Amongst other launch activities planned for resveratrol in the second half of 2014, Evolva will have a booth at the SupplySide West 2014 Expo (Las Vegas, USA) October 6 to 10, 2014. At this Expo, executives from around the world gather to discuss the latest trends in the areas of animal nutrition, personal care, food, beverage and dietary supplements.